ALS LIMITED (ALQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALQ

ALQ - ALS LIMITED

FNArena Sector : Industrial Sector Contractors & Engineers
Year End: March
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 1.88
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

ALS Ltd provides laboratory and testing services across the mining, industrial and life sciences sector. It operates in over 65 countries. Formerly Campbell Brothers Ltd it first listed in 1952 and changed name to ALS in 2012.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$21.83

18 May
2026

-0.370

OPEN

$22.00

-1.67%

HIGH

$22.90

2,604,784

LOW

$21.32

TARGET
$25.18

-0.58 change from previous day

 15.3% upside
Franking for last dividend paid out: 30%
OTHER COMPANIES IN THE SAME SECTOR
3DA . AVD . BOL . BSA . BWN . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGL . FLC . IPG . LBL . MAD . MPW . PPK . RWL . SDV . SHA . SND . SSM . SYL . TEA . VBC . VEE . VNT . VYS .
FNARENA'S MARKET CONSENSUS FORECASTS
ALQ: 1
Title FY25
Actual		 FY26
Actual		 FY27
Forecast		 FY28
Forecast
EPS (cps) xxx 65.7 87.3 xxx
DPS (cps) xxx 0.0 50.2 xxx
EPS Growth xxx 24.2% 32.8% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 26.7 xxx
Dividend Yield xxx N/A 2.2% xxx
Div Pay Ratio(%) xxx N/A 57.5% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/11 - ex-div 19.4c (franking 30%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx65.7
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx3,320.1 M
Book Value Per Share xxxxxxxxxxxxxxx335.2
Net Operating Cash Flow xxxxxxxxxxxxxxx494.5 M
Net Profit Margin xxxxxxxxxxxxxxx9.60 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx21.39 %
Return on Invested Capital xxxxxxxxxxxxxxx10.02 %
Return on Assets xxxxxxxxxxxxxxx7.89 %
Return on Equity xxxxxxxxxxxxxxx21.39 %
Return on Total Capital xxxxxxxxxxxxxxx17.49 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx37.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx117 M
Long Term Debt xxxxxxxxxxxxxxx1,455 M
Total Debt xxxxxxxxxxxxxxx1,572 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx150 M
Price To Book Value xxxxxxxxxxxxxxx6.20

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx263.0 M
Capex % of Sales xxxxxxxxxxxxxxx7.92 %
Cost of Goods Sold xxxxxxxxxxxxxxx2,282 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx455 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx43 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

19/05/2026

2

Accumulate

$23.20

6.28%

Ord Minnett views ALS Ltd's FY26 result positively. Earnings (EBIT) and profit finished modestly ahead of consensus expectations, driven by stronger-than-expected performance in Commodities, particularly Minerals, the analyst explains.

Life Sciences disappointed due to operational disruptions and margin pressure, the broker observes, though management expects conditions to improve in FY27.

Commentary notes management pointed to a more challenging FY27 earnings backdrop, reflecting larger foreign exchange headwinds and supply chain disruption linked to the Middle East conflict.

The broker expects these pressures to be partly offset by continued strength in Minerals volumes and margins. Here, improving geochemistry demand and increased activity from junior miners is seen as supporting upside risk to guidance.

Ord Minnett retains an Accumulate rating but trims its target price to $23.20 from $23.95 following minor earnings forecast downgrades.

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

19/05/2026

4

Underweight

$18.90

-13.42%

Jarden maintains an Underweight rating for ALS Ltd while lifting the 12-month target price to $18.90 from $18.10 following changes to long-run earnings models.

The company delivered a modest financial year 2026 core net profit after tax of $381m, marking 26% growth on the prior year.

Strong performance within the commodities division through the second half offset ongoing structural volume challenges inside the North American environmental operations of the life sciences business.

Potential transaction risks from foreign exchange translation headwinds and a $5m to $10m procurement cost drag in the Middle East are expected to limit near-term outperformance.

Core earnings per share forecasts have been adjusted by 0.4% for FY27 and -1.2% for FY28, with current high relative trading multiples suggesting the valuation is fully stretched.
Access Extra Coverage Research History >

ALQ STOCK CHART

FNArena News on ALQ

1
Australian Broker Call *Extra* Edition – May 13, 2026

May 13 2026 - Daily Market Reports
2
Rudi’s View: AI, The Great Market Divider

May 06 2026 - Rudi's View
3
Rudi’s View: More Downgrades Are Coming

Apr 29 2026 - Rudi's View
4
Rudi’s View: Best Buys & Conviction Calls

Apr 23 2026 - Rudi's View
5
Rudi’s View: Top Picks & Conviction Buys

Mar 19 2026 - Rudi's View

Latest Industrial Sector Contractors & Engineers News

1
Ventia Services Targeting Key Growth Sectors

May 11 2026 - Small Caps
2
Cleanaway Eyes Margin Growth, Cash Upside

Apr 24 2026 - Australia
3
Fortress Australia: Identifying The ‘Real’ Beneficiaries Of The $330bn Defence Pipeline

Mar 23 2026 - Small Caps
4
The Great Capex Catch-Up: When Infrastructure Pipelines Meet a Commodity Gale

Feb 10 2026 - Australia
5
ALS Shares Resuming Uptrend

Feb 10 2026 - Technicals
6
Downer EDI Brimming With Confidence

Dec 03 2025 - Australia
7
ALS Strikes Gold, With Upside Potential

Nov 21 2025 - Australia
8
Can Ventia Continue to Re-Rate?

Nov 10 2025 - Small Caps
9
Water Megatrend 2.0: Regulations Force Multi-Billion Dollar Investment Boom

Oct 27 2025 - ESG Focus
10
Quenching Growth: How New Desalination Plants Could Boost ASX Stocks

Oct 13 2025 - ESG Focus